Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs

被引:23
作者
Butwick, A. J. [1 ]
Carvalho, B. [1 ]
机构
[1] Stanford Univ, Dept Anaesthesiol, Sch Med, Stanford, CA 94305 USA
关键词
MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; SYNTHETIC PENTASACCHARIDE; PHARMACOKINETIC PROFILE; VENOUS THROMBOEMBOLISM; DOSE PHARMACODYNAMICS; PREGNANT-WOMEN; 3RD TRIMESTER; HIGH-RISK; FONDAPARINUX;
D O I
10.1016/j.ijoa.2009.06.008
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:193 / 201
页数:9
相关论文
共 50 条
[21]   Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesia [J].
Knoerlein, Julian ;
Brodbeck, Philipp ;
Buechsel, Martin ;
Zieger, Barbara ;
Schmutz, Axel .
REGIONAL ANESTHESIA AND PAIN MEDICINE, 2023, 48 (05) :211-216
[22]   How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy [J].
Schulman, Sam .
BLOOD, 2017, 129 (25) :3285-3293
[23]   Initiating and Managing Patients with Venous Thromboembolism on Anticoagulant Drugs: A Practical Overview [J].
Kasthuri, Raj S. ;
Moll, Stephan .
SEMINARS IN INTERVENTIONAL RADIOLOGY, 2017, 34 (01) :3-10
[24]   Established and new-generation antithrombotic drugs in patients with cirrhosis - Possibilities and caveats [J].
Lisman, Ton ;
Kamphuisen, Pieter W. ;
Northup, Patrick G. ;
Porte, Robert J. .
JOURNAL OF HEPATOLOGY, 2013, 59 (02) :358-366
[25]   Pulmonary embolism in critically ill patients receiving antithrombotic prophylaxis: A clinical-pathologic study [J].
Berlot, Giorgio ;
Calderan, Cristina ;
Vergolini, Antonella ;
Bianchi, Monica ;
Viviani, Marino ;
Bussani, Rossana ;
Torelli, Lucio ;
Lucangelo, Umberto .
JOURNAL OF CRITICAL CARE, 2011, 26 (01) :28-33
[26]   Risk of Cardiovascular Disease Due to General Anesthesia and Neuraxial Anesthesia in Lower-Limb Fracture Patients: A Retrospective Population-Based Cohort Study [J].
Yeh, Han-Wei ;
Yeh, Liang-Tsai ;
Chou, Ying-Hsiang ;
Yang, Shun-Fa ;
Ho, Sai-Wai ;
Yeh, Ying-Tung ;
Yeh, Ying-Ting ;
Wang, Yu-Hsun ;
Chan, Chi-Ho ;
Yeh, Chao-Bin .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
[27]   How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"? [J].
Airaksinen, K. E. Juhani ;
Schlitt, Axel ;
Rubboli, Andrea ;
Karjalainen, Pasi ;
Lip, Gregory Y. H. .
EUROINTERVENTION, 2010, 6 (04) :520-526
[28]   Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs [J].
Thiefin, Gerard ;
Schwalm, Marie-Sophie .
DIGESTIVE AND LIVER DISEASE, 2011, 43 (03) :209-214
[29]   Do patients with immune-mediated thrombotic thrombocytopenic purpura receiving caplacizumab need antithrombotic therapy? [J].
Elverdi, Tugrul ;
Ozer Cerme, Melis Dila ;
Aydin, Tahacan ;
Eskazan, Ahmet Emre .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (10) :1183-1188
[30]   Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry [J].
Nieto, J. A. ;
Solano, R. ;
Ruiz-Ribo, M. D. ;
Ruiz-Gimenez, N. ;
Prandoni, P. ;
Kearon, C. ;
Monreal, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) :1216-1222